Dr. Eva María Ciruelos Gil is a medical oncologist associated with Hospital Universitario 12 de Octubre in Madrid, Spain. She is listed by the hospital as a medical oncology specialist and coordinator of its Breast and Gynecological Cancer Unit. Her clinical field includes the medical management of breast malignancies and cancers affecting the female reproductive system.

Medical Oncology and Professional Background

Medical oncology focuses on the use of systemic treatments to manage cancer. These treatments may include chemotherapy, hormone therapy, targeted medicines, immunotherapy, and other drug-based approaches selected according to the type and characteristics of the cancer.

Dr. Ciruelos is associated with the hospital's Medical Oncology Department, which provides outpatient consultations, inpatient care, oncology services, supportive care, and access to clinical research programs. The department's official information also identifies her as a university teaching associate in medical oncology.

Her role coordinating the Breast and Gynecological Cancer Unit places her within a specialist multidisciplinary service for patients requiring evaluation and treatment of breast and gynecological malignancies.

Breast Cancer Diagnosis and Treatment

Breast cancer is a group of diseases that differ according to their biological characteristics, stage, and response to treatment. The treatment plan depends on factors such as tumor size, lymph node involvement, hormone receptor status, HER2 status, molecular findings, previous treatment, and the patient's overall health.

Medical oncologists review pathology and imaging reports to determine which systemic treatments may be appropriate. Depending on the diagnosis, treatment can include hormone therapy, chemotherapy, targeted medicines, or other systemic approaches.

For selected patients, treatment may be provided before surgery to reduce tumor size or assess response. In other situations, systemic therapy may be recommended after surgery to reduce the risk of recurrence or to treat advanced disease.

Treatment decisions are made collaboratively with breast surgeons, radiologists, pathologists, radiation oncologists, and other specialists. A personalized plan requires a review of the patient's diagnostic findings and medical history.

Gynecological Oncology

Gynecological cancers include malignancies affecting the ovaries, uterus, cervix, and other organs of the female reproductive system. The appropriate treatment depends on the cancer's origin, stage, histological type, molecular characteristics, and previous therapies.

Medical oncology may form part of treatment for ovarian, endometrial, cervical, and other gynecological malignancies. Depending on the case, patients may receive chemotherapy, targeted therapies, immunotherapy, hormone-based treatments, surgery, or radiation therapy in a coordinated treatment plan.

Some gynecological cancers require molecular or genetic assessment to help guide treatment or identify inherited cancer risks. Testing is recommended according to clinical indications and the patient's family and personal history.

Multidisciplinary Cancer Care

Cancer management frequently requires coordinated input from multiple specialties. Breast and gynecological cancer care may involve medical oncologists, surgical oncologists, gynecologists, breast surgeons, radiation oncologists, radiologists, pathologists, genetics professionals, and supportive care teams.

Hospital Universitario 12 de Octubre's Medical Oncology Department includes dedicated clinical units for breast and gynecological cancers. The official physician directory identifies Dr. Ciruelos as coordinator of this unit.

The hospital's oncology services include outpatient consultations, hospital treatment, urgent oncology care, clinical trials, and supportive services. This organizational structure allows patients to be referred to relevant specialists according to their diagnosis and treatment requirements.

Clinical Research and Individualized Treatment

Oncology research examines new therapies, combinations of existing treatments, and approaches to improve diagnosis and treatment selection. Clinical trials may be available for selected patients, subject to eligibility criteria, recruitment status, and medical assessment.

A physician's affiliation with an oncology department does not mean that every trial or investigational treatment is available to every patient. Patients should ask the treating team about current options, expected benefits, risks, and alternatives.

Information for International Patients

Patients travelling to Spain for a breast or gynecological oncology consultation should prepare pathology reports, biopsy results, breast imaging, CT or MRI reports, previous surgical records, molecular test results, and a list of medications and prior cancer treatments.

For patients with a family history of breast or ovarian cancer, relevant family medical information may also help guide the consultation. Genetic testing, if indicated, requires appropriate counseling and assessment.

Dr. Eva Ciruelos Gil is listed by Hospital Universitario 12 de Octubre as a medical oncologist and coordinator of its Breast and Gynecological Cancer Unit. Her profile is relevant to patients researching specialist breast and gynecological cancer care in Madrid.